person · Reporting owner
CUNNINGHAM SEAN LAURENCE
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MARAVAI LIFESCIENCES HOLDINGS, INC.MRVI · Entity 4291 | Director | May 26, 2026 | May 28, 2026 |
| Sotera Health CoSHC · Entity 3869 | Director | May 22, 2026 | May 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MARAVAI LIFESCIENCES HOLDINGS, INC.
Report date May 26, 2026 · Filed May 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 184,348 |
Reported balance
After 2026-05-26 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-26 · Grant · Acquired 46,293 · Balance 184,348 F1: Represents restricted stock units awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan on May 26, 2026, which vest in full upon the earlier of one year from the date of grant or the date of the 2027 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders. F2: The Reporting Person holds these securities of the Issuer for the benefit of a GTCR-affiliated entity. Pursuant to the policies of the GTCR-affiliated entities, the Reporting Person must hold the securities on behalf of and for the benefit of the GTCR-affiliated entity. The Reporting Person disclaims any pecuniary interest in the securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan on May 26, 2026, which vest in full upon the earlier of one year from the date of grant or the date of the 2027 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders.
F2: The Reporting Person holds these securities of the Issuer for the benefit of a GTCR-affiliated entity. Pursuant to the policies of the GTCR-affiliated entities, the Reporting Person must hold the securities on behalf of and for the benefit of the GTCR-affiliated entity. The Reporting Person disclaims any pecuniary interest in the securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16.
Sotera Health Co
Report date May 22, 2026 · Filed May 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par value per share ("Common Stock")SEC Table I · non-derivative | Direct | 95,751 |
Reported balance
After 2026-05-22 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-22 · Grant · Acquired 14,970 · Balance 95,751 F1: These securities consist of 14,970 restricted stock units ("RSUs") that were granted on May 22, 2026, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incenctive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date. F2: These securities consist of 14,970 RSUs and 80,781 shares of Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities consist of 14,970 restricted stock units ("RSUs") that were granted on May 22, 2026, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incenctive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date.
F2: These securities consist of 14,970 RSUs and 80,781 shares of Common Stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 26, 2026 Filed May 28, 2026 22:24 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | GrantClass A Common Stock | 46,293 | $0.00 | $0.00 |
DisclosureSEC source: 0001829753-26-000001 · wk-form4_1780007091.xml · nonDerivative · entry 1 CUNNINGHAM SEAN LAURENCE · CIK 0001829753 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 184,348 F1 · shares: Represents restricted stock units awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan on May 26, 2026, which vest in full upon the earlier of one year from the date of grant or the date of the 2027 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders. F2 · balance_after: The Reporting Person holds these securities of the Issuer for the benefit of a GTCR-affiliated entity. Pursuant to the policies of the GTCR-affiliated entities, the Reporting Person must hold the securities on behalf of and for the benefit of the GTCR-affiliated entity. The Reporting Person disclaims any pecuniary interest in the securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16. Read SEC document |
| May 22, 2026 Filed May 27, 2026 21:38 UTC | Sotera Health Co SHC · Entity 3869 | GrantCommon Stock, $0.01 par value per share ("Common Stock") | 14,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-242237 · ownership.xml · nonDerivative · entry 1 CUNNINGHAM SEAN LAURENCE · CIK 0001829753 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,751 F1 · shares: These securities consist of 14,970 restricted stock units ("RSUs") that were granted on May 22, 2026, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incenctive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date. F2 · balance_after: These securities consist of 14,970 RSUs and 80,781 shares of Common Stock. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 22:24 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | GrantClass A Common Stock | 89,139 | $2.16 | $192,540.24 |
DisclosureSEC source: 0001823239-25-000084 · wk-form4_1750285473.xml · nonDerivative · entry 1 CUNNINGHAM SEAN LAURENCE · CIK 0001829753 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,055 F1 · shares: Represents restricted stock units awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan on June 16, 2025, which vest in full upon the earlier of one year from the date of grant or the date of the 2026 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders. F2 · balance_after: The Reporting Person holds these securities of the Issuer for the benefit of a GTCR-affiliated entity. Pursuant to the policies of the GTCR-affiliated entities, the Reporting Person must hold the securities on behalf of and for the benefit of the GTCR-affiliated entity. The Reporting Person disclaims any pecuniary interest in the securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16. Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:39 UTC | Sotera Health Co SHC · Entity 3869 | GrantCommon Stock, $0.01 par value per share ("Common Stock") | 19,132 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-077785 · ownership.xml · nonDerivative · entry 1 CUNNINGHAM SEAN LAURENCE · CIK 0001829753 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,781 F1 · shares: These securities consist of 19,132 restricted stock units ("RSUs") that were granted on May 22, 2025, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incenctive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date. F2 · balance_after: These securities consist of 19,132 RSUs and 61,649 shares of Common Stock. Read SEC document |
| May 24, 2024 Filed May 29, 2024 20:28 UTC | Sotera Health Co SHC · Entity 3869 | GrantCommon Stock, $0.01 par value per share ("Common Stock") | 20,089 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-065973 · ownership.xml · nonDerivative · entry 1 CUNNINGHAM SEAN LAURENCE · CIK 0001829753 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,649 F1 · shares: These securities consist of 20,089 Restricted Stock Units ("RSUs") that were granted on May 24, 2024, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date. F2 · balance_after: These securities consist of 20,089 RSUs and 41,560 shares of Common Stock. Read SEC document |
| May 23, 2024 Filed May 24, 2024 21:58 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | GrantClass A Common Stock | 20,645 | $10.78 | $222,553.10 |
DisclosureSEC source: 0001823239-24-000079 · wk-form4_1716587911.xml · nonDerivative · entry 1 CUNNINGHAM SEAN LAURENCE · CIK 0001829753 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,916 F1 · shares: Represents restricted stock units granted on May 23, 2024, which vest in full upon the earlier of one year from the date of grant or the date of the 2025 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders. F2 · balance_after: The Reporting Person holds these securities of the Issuer for the benefit of a GTCR-affiliated entity. Pursuant to the policies of the GTCR-affiliated entities, the Reporting Person must hold the securities on behalf of and for the benefit of the GTCR-affiliated entity. The Reporting Person disclaims any pecuniary interest in the securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16. Read SEC document |
| July 17, 2023 Filed Jul 19, 2023 20:50 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | GrantClass A Common Stock | 24,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001823239-23-000063 · wf-form4_168979980913958.xml · nonDerivative · entry 1 CUNNINGHAM SEAN LAURENCE · CIK 0001829753 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,271 F1 · shares: Represents restricted stock units granted on July 17, 2023, which vest in full upon the earlier of one year from the date of grant or the date of the 2024 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders. F2 · balance_after: The Reporting Person holds these securities of the Issuer for the benefit of a GTCR-affiliated entity. Pursuant to the policies of the GTCR-affiliated entities, the Reporting Person must hold the securities on behalf of and for the benefit of the GTCR-affiliated entity. The Reporting Person disclaims any pecuniary interest in the securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16. Read SEC document |
| May 26, 2023 Filed May 31, 2023 20:58 UTC | Sotera Health Co SHC · Entity 3869 | GrantCommon Stock, $0.01 par value per share (Common Stock) | 15,712 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-033126 · doc4.xml · nonDerivative · entry 1 CUNNINGHAM SEAN LAURENCE · CIK 0001829753 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,560 F1 · shares: These securities consist of 15,712 Restricted Stock Units ("RSUs") that were granted on May 26, 2023, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date. F2 · balance_after: These securities consist of 15,712 RSUs and 25,848 shares of Common Stock. Read SEC document |
| May 27, 2022 Filed May 31, 2022 21:30 UTC | Sotera Health Co SHC · Entity 3869 | GrantCommon Stock, $0.01 par value per share ("Common Stock") | 10,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001822479-22-000032 · wf-form4_165403261165333.xml · nonDerivative · entry 1 CUNNINGHAM SEAN LAURENCE · CIK 0001829753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,848 F1 · shares: These securities consist of 10,643 Restricted Stock Units ("RSUs") that were granted on May 27, 2022, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date. F2 · balance_after: These securities consist of 10,643 RSUs and 15,205 shares of Common Stock. Read SEC document |
| November 19, 2021 Filed Nov 23, 2021 21:15 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | GrantClass A Common Stock | 4,271 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-045767 · doc4.xml · nonDerivative · entry 1 CUNNINGHAM SEAN LAURENCE · CIK 0001829753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,271 F1 · shares: Represents restricted stock units ("RSUs") granted on November 19, 2021, which vest in full one year from the date of the grant. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 22:53 UTC | Sotera Health Co SHC · Entity 3869 | GrantCommon Stock, $0.01 par value per share ("Common Stock") | 9,336 | $0.00 | $0.00 |
DisclosureSEC source: 0001822479-21-000037 · wf-form4_162258795898920.xml · nonDerivative · entry 1 CUNNINGHAM SEAN LAURENCE · CIK 0001829753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,205 F1 · shares: These securities consist of 9,336 Restricted Stock Units ("RSUs") that were granted on May 28, 2021, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date. F2 · balance_after: These securities consist of 9,336 RSUs and 5,869 shares of Common Stock. Read SEC document |
| November 20, 2020 Filed Nov 25, 2020 00:00 UTC | Sotera Health Co SHC · Entity 3869 | GrantCommon Stock, $0.01 par value per share ("Common Stock") | 5,869 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-032082 · doc4.xml · nonDerivative · entry 1 CUNNINGHAM SEAN LAURENCE · CIK 0001829753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,869 F1 · shares: These securities consist of 5,869 Restricted Stock Units ("RSUs") that were granted on November 20, 2020, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.